Bank Julius Baer & Co. Ltd Zurich Invests $115,000 in Amdocs Limited (NASDAQ:DOX)

Bank Julius Baer & Co. Ltd Zurich bought a new position in shares of Amdocs Limited (NASDAQ:DOXFree Report) during the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor bought 1,225 shares of the technology company’s stock, valued at approximately $115,000.

A number of other institutional investors also recently modified their holdings of the company. Janus Henderson Group PLC raised its position in shares of Amdocs by 1.7% during the third quarter. Janus Henderson Group PLC now owns 6,625,875 shares of the technology company’s stock worth $579,632,000 after purchasing an additional 111,357 shares during the period. Pzena Investment Management LLC raised its position in Amdocs by 12.3% in the 3rd quarter. Pzena Investment Management LLC now owns 6,363,739 shares of the technology company’s stock valued at $556,700,000 after buying an additional 696,136 shares during the last quarter. Allspring Global Investments Holdings LLC raised its position in Amdocs by 2.8% in the 4th quarter. Allspring Global Investments Holdings LLC now owns 3,263,591 shares of the technology company’s stock valued at $274,681,000 after buying an additional 87,801 shares during the last quarter. Wellington Management Group LLP raised its position in Amdocs by 0.8% in the 3rd quarter. Wellington Management Group LLP now owns 2,136,932 shares of the technology company’s stock valued at $186,939,000 after buying an additional 16,580 shares during the last quarter. Finally, Pacer Advisors Inc. raised its position in Amdocs by 7.4% in the 4th quarter. Pacer Advisors Inc. now owns 1,815,675 shares of the technology company’s stock valued at $154,587,000 after buying an additional 125,654 shares during the last quarter. 92.02% of the stock is owned by institutional investors and hedge funds.

Analyst Ratings Changes

DOX has been the subject of a number of analyst reports. Oppenheimer increased their price target on Amdocs from $98.00 to $105.00 and gave the company an “outperform” rating in a research report on Wednesday, November 13th. Barclays lowered their price target on Amdocs from $113.00 to $111.00 and set an “overweight” rating for the company in a research report on Thursday, November 14th. Finally, StockNews.com lowered Amdocs from a “strong-buy” rating to a “buy” rating in a research report on Friday, February 28th. One research analyst has rated the stock with a hold rating and five have given a buy rating to the company. Based on data from MarketBeat, the company presently has an average rating of “Moderate Buy” and an average target price of $101.20.

View Our Latest Analysis on DOX

Amdocs Trading Down 1.9 %

Shares of Amdocs stock opened at $88.79 on Wednesday. Amdocs Limited has a 1 year low of $74.41 and a 1 year high of $93.83. The firm has a market cap of $10.02 billion, a PE ratio of 20.60, a P/E/G ratio of 1.47 and a beta of 0.68. The stock has a fifty day moving average price of $86.54 and a 200-day moving average price of $87.03. The company has a debt-to-equity ratio of 0.22, a current ratio of 1.16 and a quick ratio of 1.20.

Amdocs (NASDAQ:DOXGet Free Report) last announced its earnings results on Tuesday, February 4th. The technology company reported $1.45 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.64 by ($0.19). Amdocs had a net margin of 10.19% and a return on equity of 18.89%. Equities research analysts anticipate that Amdocs Limited will post 6.21 EPS for the current year.

Amdocs Increases Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, April 25th. Stockholders of record on Monday, March 31st will be given a dividend of $0.527 per share. The ex-dividend date is Monday, March 31st. This is a positive change from Amdocs’s previous quarterly dividend of $0.48. This represents a $2.11 annualized dividend and a dividend yield of 2.37%. Amdocs’s dividend payout ratio (DPR) is currently 48.72%.

Amdocs Company Profile

(Free Report)

Amdocs Limited, through its subsidiaries, provides software and services worldwide. It designs, develops, operates, implements, supports, and markets open and modular cloud portfolio. The company provides CES23, a 5G and cloud-native microservices-based market-leading customer experience suite, that enables service providers to build, deliver, and monetize advanced services; Amdocs Subscription Marketplace, a software-as-a-service-based platform that includes an expansive network of pre-integrated digital services, such as media, gaming, eLearning, sports, and retail to security and business services; the monetization suite for charging, billing, policy, and revenue management; Intelligent networking suite with a set of modular, flexible, and open service lifecycle management capabilities for network automation journeys; amAIz, a telco GenAI framework; Amdocs Digital Brands Suite, a pre-integrated digital business suite; and Amdocs eSIM Cloud for service providers.

Further Reading

Want to see what other hedge funds are holding DOX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Amdocs Limited (NASDAQ:DOXFree Report).

Institutional Ownership by Quarter for Amdocs (NASDAQ:DOX)

Receive News & Ratings for Amdocs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amdocs and related companies with MarketBeat.com's FREE daily email newsletter.